Literature DB >> 16982933

An unconventional antigen translated by a novel internal ribosome entry site elicits antitumor humoral immune reactions.

Zeyu Xiong1, Enli Liu, Yan Yan, Richard T Silver, Fan Yang, Irene H Chen, Yangyang Chen, Srdan Verstovsek, Hong Wang, Josef Prchal, Xiao-Feng Yang.   

Abstract

Self-tumor Ags that elicit antitumor immune responses in responses to IFN-alpha stimulation remain poorly defined. We screened a human testis cDNA library with sera from three polycythemia vera patients who responded to IFN-alpha and identified a novel Ag, MPD6. MPD6 belongs to the group of cryptic Ags without conventional genomic structure and is encoded by a cryptic open reading frame located in the 3'-untranslated region of myotrophin mRNA. MPD6 elicits IgG Ab responses in a subset of polycythemia vera patients, as well as patients with chronic myelogenous leukemia and prostate cancer, suggesting that it is broadly immunogenic. The expression of myotrophin-MPD6 transcripts was up-regulated in some tumor cells, but only slightly increased in K562 cells in response to IFN-alpha treatment. By using bicistronic reporter constructs, we showed that the translation of MPD6 was mediated by a novel internal ribosome entry site (IRES) upstream of the MPD6 reading frame. Furthermore, the MPD6-IRES-mediated translation, but not myotrophin-MPD6 transcription, was significantly up-regulated in response to IFN-alpha stimulation. These findings demonstrate that a novel IRES-mediated mechanism may be responsible for the translation of unconventional self-Ag MPD6 in responsive to IFN-alpha stimulation. The eliciting antitumor immune response against unconventional Ag MPD6 in patients with myeloproliferative diseases suggests MPD6 as a potential target of novel immunotherapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16982933      PMCID: PMC3902139          DOI: 10.4049/jimmunol.177.7.4907

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  80 in total

Review 1.  Internal ribosome initiation of translation and the control of cell death.

Authors:  M Holcik; N Sonenberg; R G Korneluk
Journal:  Trends Genet       Date:  2000-10       Impact factor: 11.639

2.  A new internal-ribosome-entry-site motif potentiates XIAP-mediated cytoprotection.

Authors:  M Holcik; C Lefebvre; C Yeh; T Chow; R G Korneluk
Journal:  Nat Cell Biol       Date:  1999-07       Impact factor: 28.824

3.  c-Myc protein synthesis is initiated from the internal ribosome entry segment during apoptosis.

Authors:  M Stoneley; S A Chappell; C L Jopling; M Dickens; M MacFarlane; A E Willis
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

Review 4.  Cancer vaccine: identification of human tumor antigens by SEREX.

Authors:  Y T Chen
Journal:  Cancer J       Date:  2000-05       Impact factor: 3.360

Review 5.  Interferon alpha in the treatment of polycythemia vera.

Authors:  E Lengfelder; U Berger; R Hehlmann
Journal:  Ann Hematol       Date:  2000-03       Impact factor: 3.673

6.  Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia.

Authors:  J J Molldrem; P P Lee; C Wang; K Felio; H M Kantarjian; R E Champlin; M M Davis
Journal:  Nat Med       Date:  2000-09       Impact factor: 53.440

7.  Detection of a potent humoral response associated with immune-induced remission of chronic myelogenous leukemia.

Authors:  C J Wu; X F Yang; S McLaughlin; D Neuberg; C Canning; B Stein; E P Alyea; R J Soiffer; G Dranoff; J Ritz
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

8.  Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses.

Authors:  E Jäger; Y Nagata; S Gnjatic; H Wada; E Stockert; J Karbach; P R Dunbar; S Y Lee; A Jungbluth; D Jäger; M Arand; G Ritter; V Cerundolo; B Dupont; Y T Chen; L J Old; A Knuth
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

Review 9.  Role of interferon-alpha and clonally expanded T cells in the immunotherapy of chronic myelogenous leukemia.

Authors:  S Fujii
Journal:  Leuk Lymphoma       Date:  2000-06

Review 10.  Counterpoint. Cancer vaccines: single-epitope anti-idiotype vaccine versus multiple-epitope antigen vaccine.

Authors:  M Bhattachary-Chatterjee; R Nath Baral; S K Chatterjee; R Das; H Zeytin; M Chakraborty; K A Foon
Journal:  Cancer Immunol Immunother       Date:  2000-06       Impact factor: 6.968

View more
  14 in total

1.  Novel tumor antigens elicit anti-tumor humoral immune reactions in a subset of patients with polycythemia vera.

Authors:  Zeyu Xiong; Yan Yan; Enli Liu; Richard T Silver; Srdan Verstovsek; Fan Yang; Hong Wang; Josef Prchal; Xiao-Feng Yang
Journal:  Clin Immunol       Date:  2006-11-17       Impact factor: 3.969

Review 2.  Mammalian Polycistronic mRNAs and Disease.

Authors:  Timofey A Karginov; Daniel Parviz Hejazi Pastor; Bert L Semler; Christopher M Gomez
Journal:  Trends Genet       Date:  2016-12-21       Impact factor: 11.639

3.  Interferon-alpha targets JAK2V617F-positive hematopoietic progenitor cells and acts through the p38 MAPK pathway.

Authors:  Min Lu; Wei Zhang; Yan Li; Dmitriy Berenzon; Xiaoli Wang; Jiapeng Wang; John Mascarenhas; Mingjiang Xu; Ronald Hoffman
Journal:  Exp Hematol       Date:  2010-03-18       Impact factor: 3.084

4.  The Role of Immunogenicity in Cardiovascular Disease.

Authors:  Michael Jan; Anthony T Virtue; Meghanaben Pansuria; Jingshan Liu; Xinyu Xiong; Pu Fang; Shu Meng; Hong Wang; Xiao-Feng Yang
Journal:  World Heart J       Date:  2011-01-01

5.  A novel unconventional antigen MPD5 elicits anti-tumor humoral immune responses in a subset of patients with polycythemia vera.

Authors:  Z Xiong; E Liu; Y Yan; R T Silver; F Yang; I H Chen; I Hodge; S Verstovsek; F J Segura; H Wang; J Prchal; X F Yang
Journal:  Int J Immunopathol Pharmacol       Date:  2007 Apr-Jun       Impact factor: 3.219

6.  Canonical Secretomes, Innate Immune Caspase-1-, 4/11-Gasdermin D Non-Canonical Secretomes and Exosomes May Contribute to Maintain Treg-Ness for Treg Immunosuppression, Tissue Repair and Modulate Anti-Tumor Immunity via ROS Pathways.

Authors:  Dong Ni; TingTing Tang; Yifan Lu; Keman Xu; Ying Shao; Fatma Saaoud; Jason Saredy; Lu Liu; Charles Drummer; Yu Sun; Wenhui Hu; Jahaira Lopez-Pastrana; Jin J Luo; Xiaohua Jiang; Eric T Choi; Hong Wang; Xiaofeng Yang
Journal:  Front Immunol       Date:  2021-05-18       Impact factor: 7.561

7.  A Circulating Exosome RNA Signature Is a Potential Diagnostic Marker for Pancreatic Cancer, a Systematic Study.

Authors:  Yixing Wu; Hongmei Zeng; Qing Yu; Huatian Huang; Beatrice Fervers; Zhe-Sheng Chen; Lingeng Lu
Journal:  Cancers (Basel)       Date:  2021-05-24       Impact factor: 6.639

8.  Endothelial Immunity Trained by Coronavirus Infections, DAMP Stimulations and Regulated by Anti-Oxidant NRF2 May Contribute to Inflammations, Myelopoiesis, COVID-19 Cytokine Storms and Thromboembolism.

Authors:  Ying Shao; Jason Saredy; Keman Xu; Yu Sun; Fatma Saaoud; Charles Drummer; Yifan Lu; Jin J Luo; Jahaira Lopez-Pastrana; Eric T Choi; Xiaohua Jiang; Hong Wang; Xiaofeng Yang
Journal:  Front Immunol       Date:  2021-06-25       Impact factor: 7.561

9.  The melanoma antigens MELOE-1 and MELOE-2 are translated from a bona fide polycistronic mRNA containing functional IRES sequences.

Authors:  Delphine Carbonnelle; Virginie Vignard; Delphine Sehedic; Agnes Moreau-Aubry; Laetitia Florenceau; Maud Charpentier; Wolfgang Mikulits; Nathalie Labarriere; François Lang
Journal:  PLoS One       Date:  2013-09-25       Impact factor: 3.240

10.  Nonsense-mediated mRNA decay immunity can help identify human polycistronic transcripts.

Authors:  Guy Shahaf; Dorit Shweiki
Journal:  PLoS One       Date:  2014-03-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.